Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDICLIN AG Earnings Release 2016

May 12, 2016

280_rns_2016-05-12_10242589-9070-44e9-9e2a-77fc59eff8c6.html

Earnings Release

Open in viewer

Opens in your device viewer

News Details

Corporate | 12 May 2016 12:32

MediClin started well in the 2016 financial year

DGAP-News: MediClin AG / Key word(s): Quarter Results

2016-05-12 / 12:32

The issuer is solely responsible for the content of this announcement.


MediClin started well in the 2016 financial year.

Offenburg, 12 May 2016 – The members of the Management Board of MEDICLIN Aktiengesellschaft (MediClin) are satisfied with the business development of the first three months of the 2016 financial year.

In the first quarter of 2016, Group sales of EUR 141.9 mill. were EUR 5.3 mill. or 3.9 % higher compared to the value of the first quarter 2015. The post-acute segment recorded a sales increase by EUR 4.5 mill., while the acute segment posted a EUR 0.6 mill. and the nursing care business area a EUR 0.2 mill. increase. Thus, the positive sales development seen in 2015 continued in the first quarter of the new financial year.

Group EBIT amounted to EUR 1.7 mill. and was thus EUR 0.1 mill. higher than the previous year’s value. The post-acute segment solely contributed to the earnings improvement.

Gross investments amounted to EUR 7.1 mill. in the first quarter of the 2016 financial year (Q1 2015: EUR 6.8 mill.), pertaining mainly to the reconstruction and expansion of clinics. Capital expenditure is thus in line with the annual budget. Cash and cash equivalents as of 31 March 2016 amounted to EUR 25.0 mill. (31.12.2015: EUR 29.5 mill.).

The good start into the 2016 financial year indicates that the sales and earnings targets for the Group and the segments can be achieved.

The interim report for the period from 1 January 2016 to 31 March 2016 is available under www.mediclin.de .

About MediClin AG (Ticker: MED; WKN: 659 510)

MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics, 7 nursing care facilities and 8 medical care centres in 11 federal states MediClin has a total capacity of approximately 8,000 beds. MediClins’ facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 9,000 employees.

MediClin ─ a company of the Asklepios Group


2016-05-12 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-189
Fax: +49 (0)781 488-184
E-mail: [email protected]
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart
End of News DGAP News Service

show this